148 related articles for article (PubMed ID: 31876781)
1. A Case of Novel GATA-1 Mutation-positive Transient Abnormal Myelopoiesis With Life-threatening Complications in a Neonate With Down Syndrome.
Sah RR; Ray S; Bhatia P; Dhir SK; Totadri S; Kumar N; Kumar P
J Pediatr Hematol Oncol; 2021 Mar; 43(2):e292-e295. PubMed ID: 31876781
[TBL] [Abstract][Full Text] [Related]
2. Distinct GATA1 Point Mutations in Monozygotic Twins With Down Syndrome and Transient Abnormal Myelopoiesis From a Triplet Pregnancy: A Case Report and Review of Literature.
Yin L; Lovell MA; Wilson ML; Wei Q; Liang X
Am J Clin Pathol; 2016 Dec; 146(6):753-759. PubMed ID: 28028114
[TBL] [Abstract][Full Text] [Related]
3. Naturally occurring oncogenic GATA1 mutants with internal deletions in transient abnormal myelopoiesis in Down syndrome.
Toki T; Kanezaki R; Kobayashi E; Kaneko H; Suzuki M; Wang R; Terui K; Kanegane H; Maeda M; Endo M; Mizuochi T; Adachi S; Hayashi Y; Yamamoto M; Shimizu R; Ito E
Blood; 2013 Apr; 121(16):3181-4. PubMed ID: 23440243
[TBL] [Abstract][Full Text] [Related]
4. Placental Pathology in Down Syndrome-Associated Transient Abnormal Myelopoiesis.
Kuo E; Kumarapeli AR
Arch Pathol Lab Med; 2020 Mar; 144(3):388-393. PubMed ID: 30969155
[TBL] [Abstract][Full Text] [Related]
5. Transient abnormal myelopoiesis in non-Down syndrome neonate.
Ohkawa T; Miyamoto S; Sugie M; Tomizawa D; Imai K; Nagasawa M; Morio T; Mizutani S; Takagi M
Pediatr Int; 2015; 57(1):e14-7. PubMed ID: 25711269
[TBL] [Abstract][Full Text] [Related]
6. Mutation characterization in the GATA-1 gene in patients with Down's Syndrome diagnosed with transient abnormal myelopoiesis or acute megakaryoblastic leukemia.
Mansini AP; Rubio PL; Rossi JG; Gallego MS; Medina A; Zubizarreta PA; Felice MS; Alonso CN
Arch Argent Pediatr; 2013 Dec; 111(6):532-6. PubMed ID: 24196768
[TBL] [Abstract][Full Text] [Related]
7. Spontaneous resolution of transient abnormal myelopoiesis between 34 and 40 weeks gestation.
Maracaja DLV; Rinder H
Br J Haematol; 2020 Feb; 188(4):481. PubMed ID: 31815289
[No Abstract] [Full Text] [Related]
8. Recent advances in the understanding of transient abnormal myelopoiesis in Down syndrome.
Watanabe K
Pediatr Int; 2019 Mar; 61(3):222-229. PubMed ID: 30593694
[TBL] [Abstract][Full Text] [Related]
9. Enigma of myeloid proliferation in Down syndrome.
Hasegawa D
Pediatr Int; 2019 Mar; 61(3):221. PubMed ID: 30916856
[No Abstract] [Full Text] [Related]
10. Transient Abnormal Myelopoiesis and AML in Down Syndrome: an Update.
Bhatnagar N; Nizery L; Tunstall O; Vyas P; Roberts I
Curr Hematol Malig Rep; 2016 Oct; 11(5):333-41. PubMed ID: 27510823
[TBL] [Abstract][Full Text] [Related]
11. The impact of trisomy 21 on early human hematopoiesis.
Roy A; Cowan G; Vyas P; Roberts I
Cell Cycle; 2013 Feb; 12(4):533-4. PubMed ID: 23343767
[No Abstract] [Full Text] [Related]
12. The hematopoietic microenvironment of the fetal liver and transient abnormal myelopoiesis associated with Down syndrome: A review.
Miyauchi J
Crit Rev Oncol Hematol; 2024 Jul; 199():104382. PubMed ID: 38723838
[TBL] [Abstract][Full Text] [Related]
13. Complete blood count differences in a cohort of Down syndrome neonates with transient abnormal myelopoiesis screened for GATA1 pathogenic variants.
Orozco-Vela M; Corona-Rivera A; Cruz-Osorio RM; Mendoza-Maldonado L; Márquez-Mora A; Barba-Barba CC; Peña-Padilla C; Baldomero-López A; Bobadilla-Morales L; Corona-Rivera JR
Am J Med Genet A; 2020 Sep; 182(9):2085-2093. PubMed ID: 32681702
[TBL] [Abstract][Full Text] [Related]
14. Prominent megakaryocytic dysplasia after regression of transient abnormal myelopoiesis associated with GATA-1 mutation.
Anoop P; Atra A
J Pediatr Hematol Oncol; 2012 Nov; 34(8):640. PubMed ID: 23007419
[TBL] [Abstract][Full Text] [Related]
15. Transient abnormal myelopoiesis in a cytogenetically normal neonate.
Yanase K; Kato K; Katayama N; Mouri Y; Kobayashi C; Shiono J; Abe M; Yoshimi A; Koike K; Arai J; Tsuchida M
Int J Hematol; 2010 Oct; 92(3):527-30. PubMed ID: 20859711
[TBL] [Abstract][Full Text] [Related]
16. Transient abnormal myelopoiesis of a newborn not associated with chromosome 21 abnormalities or GATA1 mutations.
Nakashima MO; Shetty S; Chicka M; Flagg A; Eng C; Cotta CV
Pediatr Blood Cancer; 2015 Feb; 62(2):353-355. PubMed ID: 25175265
[TBL] [Abstract][Full Text] [Related]
17. Down syndrome-related transient abnormal myelopoiesis is attributed to a specific erythro-megakaryocytic subpopulation with
Nishinaka-Arai Y; Niwa A; Matsuo S; Kazuki Y; Yakura Y; Hiroma T; Toki T; Sakuma T; Yamamoto T; Ito E; Oshimura M; Nakahata T; Saito MK
Haematologica; 2021 Feb; 106(2):635-640. PubMed ID: 32354872
[No Abstract] [Full Text] [Related]
18. Liver fibrosis with hypereosinophilia causing transient abnormal myelopoiesis.
Minakata S; Sakata N; Wada N; Konishi Y; Marutani S; Enya T; Nakagawa H; Wada H; Takemura T
Pediatr Int; 2016 Nov; 58(11):1222-1225. PubMed ID: 27709778
[TBL] [Abstract][Full Text] [Related]
19. Twin-to-twin transmission of transient abnormal myelopoiesis without constitutional trisomy 21: A case report.
Roseman AS; Blackburn PR; Bakshi S; Grady L; Abbott MA; Hassan S; Hunt J; Richardson M; Peterson JF; Nguyen P; Greipp PT; Singh R
Cancer Genet; 2020 Jun; 244():62-64. PubMed ID: 32464589
[No Abstract] [Full Text] [Related]
20. GATA1 mutations in a cohort of Malaysian children with Down syndrome-associated myeloid disorder.
Lum SH; Choong SS; Krishnan S; Mohamed Z; Ariffin H
Singapore Med J; 2016 Jun; 57(6):320-4. PubMed ID: 27353457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
